Drug Shortage Report for DALACIN C PHOSPHATE

Last updated on 2021-02-17 History
Report ID 134268
Drug Identification Number 00260436
Brand name DALACIN C PHOSPHATE
Common or Proper name Dalacin C Phosphate
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) CLINDAMYCIN
Strength(s) 150MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 25 x 4mL vial
ATC code J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-10-30
Actual start date
Estimated end date 2022-04-01
Actual end date
Shortage status Anticipated shortage
Updated date 2021-02-17
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-02-17 French Compare
v3 2021-02-17 English Compare
v2 2021-02-17 French Compare
v1 2021-02-17 English Compare